Targeted Healthcare Partners Curve's Whole-Body Intelligence platform offers early, actionable chronic-disease insights from a blood-based Whole-Body Atlas, creating compelling opportunities to pilot and adopt within hospitals, health systems, and diagnostic laboratories.

Leadership Credibility The appointment of Amit Singal as Chief Medical Officer signals strong clinical leadership, enabling trusted physician engagement, accelerated clinical validation, and productive conversations with payers and health systems.

Validation Through Funding A major funding round from leading investors underscores market validation and provides resources to scale pilots, catalyze partnerships with pharma and CROs, and expand the commercial team.

Distinctive Diagnostic Edge The Whole-Body Atlas combined with AI-powered Whole-Body Intelligence offers earlier, organ-specific biology insights from blood, differentiating Curve from traditional diagnostics and creating partnerships with labs, biotech researchers, and pharmaceutical developers for biomarker validation and patient stratification.

Market Growth Footprint Dallas base with cross coastal operations signals access to major US markets and scalable pilots with large health systems, enabling rapid expansion through regional partnerships and channel strategies.